These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 33617131

  • 1. Post-vaccination healthcare attendance rate as a proxy measure for syndromic surveillance of adverse events following immunisation.
    Mesfin YM, Cheng AC, Enticott J, Lawrie J, Buttery J.
    Aust N Z J Public Health; 2021 Apr; 45(2):101-107. PubMed ID: 33617131
    [Abstract] [Full Text] [Related]

  • 2. Active SMS-based influenza vaccine safety surveillance in Australian children.
    Pillsbury A, Quinn H, Cashman P, Leeb A, Macartney K, AusVaxSafety consortium.
    Vaccine; 2017 Dec 18; 35(51):7101-7106. PubMed ID: 29128379
    [Abstract] [Full Text] [Related]

  • 3. General practice encounters following seasonal influenza vaccination as a proxy measure of early-onset adverse events.
    Dey A, Gidding HF, Menzies R, McIntyre P.
    Vaccine; 2014 Apr 17; 32(19):2204-8. PubMed ID: 24613527
    [Abstract] [Full Text] [Related]

  • 4. Allergic adverse events following 2015 seasonal influenza vaccine, Victoria, Australia.
    Clothier HJ, Crawford N, Russell MA, Buttery JP.
    Euro Surveill; 2017 May 18; 22(20):. PubMed ID: 28552101
    [Abstract] [Full Text] [Related]

  • 5. Annual report: Surveillance of adverse events following immunisation in Australia, 2011.
    Mahajan D, Cook J, Dey A, Macartney K, Menzies RI.
    Commun Dis Intell Q Rep; 2012 Dec 31; 36(4):E315-32. PubMed ID: 23330706
    [Abstract] [Full Text] [Related]

  • 6. Annual report: surveillance of adverse events following immunisation in Australia, 2004.
    Lawrence GL, Boyd I, McIntyre PB, Isaacs D.
    Commun Dis Intell Q Rep; 2005 Dec 31; 29(3):248-62. PubMed ID: 16220860
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A, Tseng HF, Greene SK, Vellozzi C, Lee GM, VSD Rapid Cycle Analysis Influenza Working Group.
    Vaccine; 2012 Mar 02; 30(11):2024-31. PubMed ID: 22361304
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of age.
    Allsup S, Gosney M, Haycox A, Regan M.
    Health Technol Assess; 2003 Mar 02; 7(24):iii-x, 1-65. PubMed ID: 14499051
    [Abstract] [Full Text] [Related]

  • 14. SAEFVIC: Surveillance of adverse events following immunisation (AEFI) in Victoria, Australia, 2018.
    Clothier HJ, Lawrie J, Lewis G, Russell M, Crawford NW, Buttery JP.
    Commun Dis Intell (2018); 2020 Jun 15; 44():. PubMed ID: 32536336
    [Abstract] [Full Text] [Related]

  • 15. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety.
    Glover C, Crawford N, Leeb A, Wood N, Macartney K.
    Vaccine; 2020 Jun 26; 38(31):4892-4900. PubMed ID: 32499067
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Annual report: surveillance of adverse events following immunisation in Australia, 2007.
    Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB.
    Commun Dis Intell Q Rep; 2008 Dec 26; 32(4):371-87. PubMed ID: 19374268
    [Abstract] [Full Text] [Related]

  • 18. Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).
    Leite A, Thomas SL, Andrews NJ.
    Vaccine; 2017 Dec 14; 35(49 Pt B):6885-6892. PubMed ID: 29056424
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.